Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-03-30 00:00:00 ET · period of report 2022-03-28 · accession 0001883850-22-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-30 | 2022-03-28 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $685.26 | -11.8K | 28.9K | -29% | -$8.10M |
| DM | 2022-03-30 | 2022-03-29 | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $687.90 | -2,683 | 30.4K | -8% | -$1.85M |
| DM | 2022-03-30 | 2022-03-28 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $426.56 | +14.5K | 30.0K | +94% | +$6.19M |
| DM | 2022-03-30 | 2022-03-28 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $0.00 | -14.5K | 13.0K | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-28 | F | D | 2,785 | $685.26 | 31,427 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-29 | S | D | 54 | $681.90 | 31,373 | D | — | — | (F2) Represents volume-weighted average price of sales of 54 shares of Company stock on March 29, 2022 at prices ranging from $681.89 to $681.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 3 | Common | Common Stock | 2022-03-29 | S | D | 103 | $682.37 | 31,270 | D | — | — | (F3) Represents volume-weighted average price of sales of 103 shares of Company stock on March 29, 2022 at prices ranging from $682.09 to $682.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 4 | Common | Common Stock | 2022-03-29 | S | D | 304 | $683.29 | 30,966 | D | — | — | (F4) Represents volume-weighted average price of sales of 304 shares of Company stock on March 29, 2022 at prices ranging from $683.06 to $683.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 5 | Common | Common Stock | 2022-03-29 | S | D | 227 | $684.45 | 30,739 | D | — | — | (F5) Represents volume-weighted average price of sales of 227 shares of Company stock on March 29, 2022 at prices ranging from $684.02 to $684.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 6 | Common | Common Stock | 2022-03-29 | S | D | 176 | $685.58 | 30,563 | D | — | — | (F6) Represents volume-weighted average price of sales of 176 shares of Company stock on March 29, 2022 at prices ranging from $685.09 to $685.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 7 | Common | Common Stock | 2022-03-29 | S | D | 220 | $687.52 | 30,151 | D | — | — | (F8) Represents volume-weighted average price of sales of 220 shares of Company stock on March 29, 2022 at prices ranging from $687.08 to $687.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 8 | Common | Common Stock | 2022-03-29 | S | D | 542 | $688.55 | 29,609 | D | — | — | (F9) Represents volume-weighted average price of sales of 542 shares of Company stock on March 29, 2022 at prices ranging from $688.00 to $688.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 9 | Common | Common Stock | 2022-03-29 | S | D | 205 | $689.33 | 29,404 | D | — | — | (F10) Represents volume-weighted average price of sales of 205 shares of Company stock on March 29, 2022 at prices ranging from $689.05 to $689.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 10 | Common | Common Stock | 2022-03-29 | S | D | 37 | $690.91 | 29,367 | D | — | — | (F11) Represents volume-weighted average price of sales of 37 shares of Company stock on March 29, 2022 at prices ranging from $690.77 to $690.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 11 | Common | Common Stock | 2022-03-29 | S | D | 226 | $691.47 | 29,141 | D | — | — | (F12) Represents volume-weighted average price of sales of 226 shares of Company stock on March 29, 2022 at prices ranging from $691.16 to $691.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 12 | Common | Common Stock | 2022-03-29 | S | D | 147 | $692.38 | 28,994 | D | — | — | (F13) Represents volume-weighted average price of sales of 147 shares of Company stock on March 29, 2022 at prices ranging from $692.18 to $692.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 13 | Common | Common Stock | 2022-03-29 | S | D | 103 | $693.18 | 28,891 | D | — | — | (F14) Represents volume-weighted average price of sales of 103 shares of Company stock on March 29, 2022 at prices ranging from $693.01 to $693.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 14 | Common | Common Stock | 2022-03-29 | S | D | 147 | $694.94 | 28,744 | D | — | — | |
| 15 | Common | Common Stock | 2022-03-28 | M | A | 3,500 | $399.66 | 34,212 | D | — | — | |
| 16 | Common | Common Stock | 2022-03-28 | F | D | 3,581 | $685.26 | 30,712 | D | — | — | |
| 17 | Common | Common Stock | 2022-03-28 | M | A | 4,500 | $399.66 | 34,293 | D | — | — | |
| 18 | Common | Common Stock | 2022-03-28 | F | D | 3,183 | $685.26 | 29,793 | D | — | — | |
| 19 | Common | Common Stock | 2022-03-28 | M | A | 4,000 | $399.66 | 32,976 | D | — | — | |
| 20 | Common | Common Stock | 2022-03-28 | F | D | 1,134 | $685.26 | 28,976 | D | — | — | |
| 21 | Common | Common Stock | 2022-03-28 | M | A | 1,250 | $555.67 | 30,110 | D | — | — | |
| 22 | Common | Common Stock | 2022-03-28 | F | D | 1,134 | $685.26 | 28,860 | D | — | — | |
| 23 | Common | Common Stock | 2022-03-28 | M | A | 1,250 | $555.67 | 29,994 | D | — | — | |
| 24 | Common | Common Stock | 2022-03-29 | S | D | 192 | $686.67 | 30,371 | D | — | — | (F7) Represents volume-weighted average price of sales of 192 shares of Company stock on March 29, 2022 at prices ranging from $686.06 to $686.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price. |
| 25 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-28 | M | D | 3,500 | $0.00 | 5,000 | D | $399.66 · — to 2024-12-16 | 3,500 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |
| 26 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-28 | M | D | 4,500 | $0.00 | 8,500 | D | $399.66 · — to 2024-12-16 | 4,500 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |
| 27 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-28 | M | D | 1,250 | $0.00 | 1,250 | D | $555.67 · — to 2025-12-16 | 1,250 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |
| 28 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-28 | M | D | 1,250 | $0.00 | 0 | D | $555.67 · — to 2025-12-16 | 1,250 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |
| 29 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-03-28 | M | D | 4,000 | $0.00 | 13,000 | D | $399.66 · — to 2024-12-16 | 4,000 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |